Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis.

[1]  Z. Zuo,et al.  Bioavailability enhancement of glucosamine hydrochloride by chitosan. , 2013, International journal of pharmaceutics.

[2]  R. Muzzarelli,et al.  Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration. , 2013, Carbohydrate polymers.

[3]  R. Scandurra,et al.  l-Carnitine enhances extracellular matrix synthesis in human primary chondrocytes , 2013, Rheumatology International.

[4]  Y. Henrotin,et al.  Chondroitin and Glucosamine in the Management of Osteoarthritis: An Update , 2013, Current Rheumatology Reports.

[5]  J. M. Erickson,et al.  Glucosamine and chondroitin sulfate treatment of hand osteoarthritis. , 2013, The Journal of hand surgery.

[6]  S. D. Artamonova,et al.  Isolation of D-glucosamine from chitin-glucan complexes , 2013, Applied Biochemistry and Microbiology.

[7]  Long Liu,et al.  Microbial production of glucosamine and N-acetylglucosamine: advances and perspectives , 2013, Applied Microbiology and Biotechnology.

[8]  S. Bae,et al.  Prevalence and factors affecting glucosamine use in Korea: a survey-based study , 2013, Rheumatology International.

[9]  J. Reginster,et al.  Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study. , 2013, Osteoarthritis and cartilage.

[10]  W. Tsai,et al.  Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer , 2013, Supportive Care in Cancer.

[11]  A. Mantalaris,et al.  Disease-modifying osteoarthritis drugs: in vitro and in vivo data on the development of DMOADs under investigation , 2013, Expert opinion on investigational drugs.

[12]  I. Nagaoka,et al.  Evaluation of the effect of glucosamine administration on biomarkers of cartilage and bone metabolism in bicycle racers. , 2013, Molecular medicine reports.

[13]  S. Darwish,et al.  The effectiveness of Echinacea extract or composite glucosamine, chondroitin and methyl sulfonyl methane supplements on acute and chronic rheumatoid arthritis rat model , 2013, Toxicology and industrial health.

[14]  P. Nair,et al.  Engineering cartilage tissue interfaces using a natural glycosaminoglycan hydrogel matrix--an in vitro study. , 2013, Materials science & engineering. C, Materials for biological applications.

[15]  Miguel Anxo Murado,et al.  Chondroitin Sulfate, Hyaluronic Acid and Chitin/Chitosan Production Using Marine Waste Sources: Characteristics, Applications and Eco-Friendly Processes: A Review , 2013, Marine drugs.

[16]  E. Otesile,et al.  Evaluation of Glucosamine and Snail Mucin on the Progression of Experimental Knee Osteoarthritis in Dogs , 2013 .

[17]  G. Alaylı,et al.  Effects of glucosamine sulfate and exercise therapy on serum leptin levels in patients with knee osteoarthritis: preliminary results of randomized controlled clinical trial , 2013, Rheumatology International.

[18]  D. Uebelhart,et al.  Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what’s the evidence? , 2013, Current medical research and opinion.

[19]  J. O’Doherty,et al.  Multi-Functional Roles of Chitosan as a Potential Protective Agent against Obesity , 2013, PloS one.

[20]  C. Baerwald,et al.  Medikamentöse Therapie der Arthrose , 2012, Aktuelle Rheumatologie.

[21]  U. Peters,et al.  Association between use of specialty dietary supplements and C-reactive protein concentrations. , 2012, American journal of epidemiology.

[22]  Z. Pietrasik,et al.  Extraction, isolation and analysis of chondroitin sulfate from broiler chicken biomass , 2012 .

[23]  B. Rocha,et al.  Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties , 2012, Arthritis Research & Therapy.

[24]  V. Pomin,et al.  Residual keratan sulfate in chondroitin sulfate formulations for oral administration. , 2012, Carbohydrate polymers.

[25]  F. Jamali,et al.  Glucosamine and adjuvant arthritis: a pharmacokinetic and pharmacodynamic study. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  P. Naumov,et al.  Glucosamine Salts: Resolving Ambiguities over the Market-Based Compositions , 2012 .

[27]  O. Gabrielli,et al.  Structural characterisation of chondroitin sulphate from Italian cheese Parmigiano-Reggiano , 2012 .

[28]  Xiong Guo,et al.  Synthesis and characterization of selenium-chondroitin sulfate nanoparticles. , 2012, Carbohydrate polymers.

[29]  I. Nagaoka,et al.  Evaluation of the effect of methionine and glucosamine on adjuvant arthritis in rats , 2012, Experimental and therapeutic medicine.

[30]  A. Sawitzke,et al.  Nutraceuticals in the Management of Osteoarthritis , 2012, Drugs & Aging.

[31]  A. Broom,et al.  Who Uses Glucosamine and Why? A Study of 266,848 Australians Aged 45 Years and Older , 2012, PloS one.

[32]  E. White,et al.  Use of glucosamine and chondroitin in relation to mortality , 2012, European Journal of Epidemiology.

[33]  M. Liu,et al.  Comparative Fasting Bioavailability and Pharmacokinetic Properties of 2 Formulations of Glucosamine Hydrochloride in Healthy Chinese Adult Male Volunteers , 2012, Arzneimittelforschung/Drug Research.

[34]  F. Jamali,et al.  Absorption and bioavailability of glucosamine in the rat. , 2012, Journal of pharmaceutical sciences.

[35]  F. Greco,et al.  Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: a review. , 2012, Carbohydrate polymers.

[36]  Ming Yang,et al.  Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study. , 2012, Osteoarthritis and cartilage.

[37]  Long Liu,et al.  Enhanced glucosamine production by Aspergillus sp. BCRC 31742 based on the time-variant kinetics analysis of dissolved oxygen level. , 2012, Bioresource technology.

[38]  Mary Susan Martin,et al.  Glucosamine and Chondroitin: An Appropriate Adjunct Treatment of Symptomatic Osteoarthritis of the Knee , 2012, Orthopedic nursing.

[39]  Y. Tokuhashi,et al.  Long‐term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up‐regulation of MMP‐3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[40]  Long Liu,et al.  Improved glucosamine and N-acetylglucosamine production by an engineered Escherichia coli via step-wise regulation of dissolved oxygen level. , 2012, Bioresource technology.

[41]  K. Rajiah,et al.  A Clinical Study on Glucosamine Sulfate versus Combination of Glucosamine Sulfate and NSAIDs in Mild to Moderate Knee Osteoarthritis , 2012, TheScientificWorldJournal.

[42]  J. Reginster,et al.  Role of glucosamine in the treatment for osteoarthritis , 2012, Rheumatology International.

[43]  I. Nagaoka,et al.  Effect of a dietary supplement containing glucosamine hydrochloride, chondroitin sulfate and quercetin glycosides on symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled study. , 2012, Journal of the science of food and agriculture.

[44]  J. López‐Cervantes,et al.  Ultra-high pressure LC determination of glucosamine in shrimp by-products and migration tests of chitosan films. , 2012, Journal of separation science.

[45]  M. Paoletti,et al.  Current views on fungal chitin/chitosan, human chitinases, food preservation, glucans, pectins and inulin: A tribute to Henri Braconnot, precursor of the carbohydrate polymers science, on the chitin bicentennial , 2012 .

[46]  Frank Beier,et al.  Emerging Frontiers in cartilage and chondrocyte biology. , 2011, Best practice & research. Clinical rheumatology.

[47]  S. Poništ,et al.  Chondroitin sulfate effect on induced arthritis in rats. , 2011, Osteoarthritis and cartilage.

[48]  C. Gabay,et al.  Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. , 2011, Arthritis and rheumatism.

[49]  N. Volpi.  Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule , 2011, Inflammopharmacology.

[50]  R. Chiusaroli,et al.  Experimental Pharmacology of Glucosamine Sulfate , 2011, International journal of rheumatology.

[51]  F. Jamali,et al.  The glucosamine controversy; a pharmacokinetic issue. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[52]  T. Kamarul,et al.  A preliminary study of the effects of glucosamine sulphate and chondroitin sulphate on surgically treated and untreated focal cartilage damage. , 2011, European cells & materials.

[53]  Hiroshi Nakamura.  Application of glucosamine on human disease—Osteoarthritis , 2011 .

[54]  J. Raynauld,et al.  Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy : a randomised , double-blind , placebo-controlled pilot study using MRI , 2022 .

[55]  E. Itoi,et al.  The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis. , 2011, Biochemical and biophysical research communications.

[56]  J. Anderson,et al.  A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals , 2010, Diabetes/metabolism research and reviews.

[57]  Y. Henrotin,et al.  Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations , 2010, Therapeutic advances in musculoskeletal disease.

[58]  A. Fosang,et al.  Identifying the human aggrecanase. , 2010, Osteoarthritis and cartilage.

[59]  N. Volpi.  About oral absorption and human pharmacokinetics of chondroitin sulfate. , 2010, Osteoarthritis and Cartilage.

[60]  C. Rubio-Terrés.  Evaluación económica del uso de condroitín sulfato y antiinflamatorios no esteroideos en el tratamiento de la artrosis. Datos del estudio VECTRA , 2010 .

[61]  C. Rubio-terrés.  [An economic evaluation of chondroitin sulfate and non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis. Data from the VECTRA study]. , 2010, Reumatologia clinica.

[62]  J. Cuevas,et al.  Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. , 2010, Osteoarthritis and cartilage.

[63]  M. Hochberg,et al.  Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. , 2010, Osteoarthritis and cartilage.

[64]  A. Garcı́a,et al.  Chondroitin sulfate inhibits lipopolysaccharide-induced inflammation in rat astrocytes by preventing nuclear factor kappa B activation , 2010, Neuroscience.

[65]  Ho-Shing Wu,et al.  Effect of pellet size and stimulating factor on the glucosamine production using Aspergillus sp. BCRC 31742. , 2010, Bioresource technology.

[66]  J. Pelletier,et al.  Variable Effects of 3 Different Chondroitin Sulfate Compounds on Human Osteoarthritic Cartilage/Chondrocytes: Relevance of Purity and Production Process , 2010, The Journal of Rheumatology.

[67]  D. Clegg,et al.  The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. , 2010, Osteoarthritis and cartilage.

[68]  R. Muzzarelli.  Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers , 2010, Marine drugs.

[69]  M. Thanou,et al.  Biodegradation, biodistribution and toxicity of chitosan. , 2010, Advanced drug delivery reviews.

[70]  M. Hiligsmann,et al.  Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysis , 2009, Journal of medical economics.

[71]  C. Clar,et al.  The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. , 2009, Health technology assessment.

[72]  S. Campo,et al.  Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. , 2009, Archives of biochemistry and biophysics.

[73]  N. Volpi.  Quality of different chondroitin sulfate preparations in relation to their therapeutic activity , 2009 .

[74]  Y. Matsusue,et al.  Chondroitin sulfate for the treatment of hip and knee osteoarthritis: current status and future trends. , 2009, Life sciences.

[75]  SG Kirkham,et al.  Review Article: Glucosamine , 2009, Journal of orthopaedic surgery.

[76]  R. Muzzarelli.  Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone , 2009 .

[77]  P. Galéra,et al.  Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. , 2009, Arthritis and rheumatism.

[78]  C. Cooper,et al.  Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system , 2008, BMC musculoskeletal disorders.

[79]  E. Huskisson.  Glucosamine and Chondroitin for Osteoarthritis , 2008, The Journal of international medical research.

[80]  S. Campo,et al.  Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice. , 2008, Osteoarthritis and cartilage.

[81]  D. Reda,et al.  The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. , 2008, Arthritis and rheumatism.

[82]  M. Hochberg,et al.  Potential effects of chondroitin sulfate on joint swelling: a GAIT report. , 2008, Osteoarthritis and cartilage.

[83]  D. Uebelhart.  Clinical review of chondroitin sulfate in osteoarthritis. , 2008, Osteoarthritis and cartilage.

[84]  H. Weinans,et al.  Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants , 2008, BMC musculoskeletal disorders.

[85]  C. Archer,et al.  Cartilage integration: evaluation of the reasons for failure of integration during cartilage repair. A review. , 2008, European cells & materials.

[86]  Nicola Volpi,et al.  Analytical aspects of pharmaceutical grade chondroitin sulfates. , 2007, Journal of pharmaceutical sciences.

[87]  Michele M. Temple,et al.  Age- and site-associated biomechanical weakening of human articular cartilage of the femoral condyle. , 2007, Osteoarthritis and cartilage.

[88]  M. Tiku,et al.  Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation , 2007, Arthritis research & therapy.

[89]  N. Rajapakse,et al.  Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells. , 2007, Bioorganic & medicinal chemistry.

[90]  R. Tuan,et al.  Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. , 2007, Osteoarthritis and cartilage.

[91]  J. Reginster,et al.  Current role of glucosamine in the treatment of osteoarthritis. , 2007, Rheumatology.

[92]  S. Reichenbach,et al.  Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip , 2007, Annals of Internal Medicine.

[93]  E. Mendis,et al.  Glucosamine sulfate promotes osteoblastic differentiation of MG-63 cells via anti-inflammatory effect. , 2007, Bioorganic & medicinal chemistry letters.

[94]  A. Shao,et al.  Risk assessment for glucosamine and chondroitin sulfate. , 2007, Regulatory toxicology and pharmacology : RTP.

[95]  B. Mazières,et al.  Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study , 2007, Annals of the rheumatic diseases.

[96]  G. Tosi,et al.  Chitosan taurocholate capacity to bind lipids and to undergo enzymatic hydrolysis: An in vitro model , 2006 .

[97]  L. Rovati,et al.  Use of crystalline glucosamine sulfate in osteoarthritis , 2006 .

[98]  P. Mourão,et al.  Effects of molecular size and chemical structure on renal and hepatic removal of exogenously administered chondroitin sulfate in rats. , 2006, Biochimica et biophysica acta.

[99]  T. McAlindon,et al.  Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness , 2005, Annals of the rheumatic diseases.

[100]  N. Poolsup,et al.  Glucosamine Long-Term Treatment and the Progression of Knee Osteoarthritis: Systematic Review of Randomized Controlled Trials , 2005, The Annals of pharmacotherapy.

[101]  G. Herrero-Beaumont,et al.  EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2005, Annals of the rheumatic diseases.

[102]  J W Anderson,et al.  Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[103]  A. Domb,et al.  Chitosan chemistry and pharmaceutical perspectives. , 2004, Chemical reviews.

[104]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[105]  T. Towheed.  Current status of glucosamine therapy in osteoarthritis. , 2003, Arthritis and rheumatism.

[106]  J. Reginster,et al.  Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. , 2003, Archives of internal medicine.

[107]  N. Volpi.  Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers. , 2003, Osteoarthritis and cartilage.

[108]  L. Lippiello,et al.  Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. , 2003, Osteoarthritis and cartilage.

[109]  G. Herrero-Beaumont,et al.  Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes , 2003 .

[110]  J. Lonner,et al.  Pharmacologic therapy for osteoarthritis. , 2002, American journal of orthopedics.

[111]  K. Pavelka,et al.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. , 2002, Archives of internal medicine.

[112]  N. Volpi,et al.  Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers. , 2002, Osteoarthritis and cartilage.

[113]  Hiromoto Ito,et al.  The effects of age and sex on chondroitin sulfates in normal synovial fluid. , 2002, Arthritis and rheumatism.

[114]  T. Iwanaga,et al.  Cellular Expression of Gut Chitinase mRNA in the Gastrointestinal Tract of Mice and Chickens , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[115]  H. Ling,et al.  The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. , 2002, The Biochemical journal.

[116]  Y. Okamoto,et al.  Enhanced healing of cartilaginous injuries by glucosamine hydrochloride , 2002 .

[117]  J. Hua,et al.  Inhibitory actions of glucosamine, a therapeutic agent for osteoarthritis, on the functions of neutrophils , 2002, Journal of leukocyte biology.

[118]  J. Bali,et al.  Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system. , 2001, Seminars in arthritis and rheumatism.

[119]  A. Place,et al.  Identification of a Novel Acidic Mammalian Chitinase Distinct from Chitotriosidase* , 2001, The Journal of Biological Chemistry.

[120]  J. Magdalou,et al.  Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. , 2001, Arthritis and rheumatism.

[121]  Eric Lejeune,et al.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.

[122]  G. Wu,et al.  Glucosamine inhibits inducible nitric oxide synthesis. , 2000, Biochemical and biophysical research communications.

[123]  T. Hammad,et al.  Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. , 2000, Osteoarthritis and cartilage.

[124]  O Habuchi,et al.  Diversity and functions of glycosaminoglycan sulfotransferases. , 2000, Biochimica et biophysica acta.

[125]  D. Felson,et al.  Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.

[126]  K. Prydz,et al.  Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.

[127]  R. W. Gracy,et al.  Therapeutic nutraceutical treatments for osteoarthritis and ischaemia , 2000 .

[128]  R. Moskowitz,et al.  Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. , 1999, Rheumatic diseases clinics of North America.

[129]  M. J. Cupp,et al.  Glucosamine sulfate use in osteoarthritis. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[130]  A. Philippi,et al.  Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. , 1999, Military medicine.

[131]  D. Aswad,et al.  Isoaspartate in Chrondroitin Sulfate Proteoglycans of Mammalian Brain* , 1998, The Journal of Biological Chemistry.

[132]  T. Conrozier.  [Chondroitin sulfates (CS 4&6): practical applications and economic impact]. , 1998, Presse medicale.

[133]  J. Sandy,et al.  Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. , 1998, The Biochemical journal.

[134]  L. Rovati,et al.  Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. , 1998, Arzneimittel-Forschung.

[135]  K. Kimata,et al.  Transient Expression of PG‐M/Versican, a Large Chondroitin Sulfate Proteoglycan in Developing Chicken Retina , 1997, Journal of neurochemistry.

[136]  R. W. Gracy,et al.  Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis. , 1996, Clinical therapeutics.

[137]  A. V. van Zonneveld,et al.  Cloning of a cDNA Encoding Chitotriosidase, a Human Chitinase Produced by Macrophages (*) , 1995, The Journal of Biological Chemistry.

[138]  F. Matsui,et al.  Brain development and multiple molecular species of proteoglycan , 1994, Neuroscience Research.

[139]  M. Fischer,et al.  Glucosamine sulfate in osteoarthritis of the knee. , 1994, Osteoarthritis and cartilage.

[140]  A. Conte,et al.  Metabolic fate of exogenous chondroitin sulfate in the experimental animal. , 1990, Arzneimittel-Forschung.

[141]  P. Marynen,et al.  Partial primary structure of the 48- and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. Prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts. , 1989, The Journal of biological chemistry.

[142]  J. Cassiman,et al.  Membrane-associated chondroitin sulfate proteoglycans of human lung fibroblasts , 1989, The Journal of cell biology.

[143]  S. Suzuki,et al.  Heterogeneity of proteochondroitin sulfates produced by chondrocytes at different stages of cytodifferentiation. , 1974, The Journal of biological chemistry.

[144]  A. J. Bollet,et al.  Biochemical Findings in Normal and Osteoarthritic Articular Cartilage. II. Chondroitin Sulfate Concentration and Chain Length, Water, and Ash Content. , 1966, The Journal of clinical investigation.

[145]  B. Matthews.  Composition of Articular Cartilage in Osteoarthritis , 1953 .

[146]  Noskov Sm,et al.  Strategy for the use of chondroprotectors in osteoarthrosis , 2013 .

[147]  R. Muzzarelli.  10.06 – Nanochitins and Nanochitosans, Paving the Way to Eco-Friendly and Energy-Saving Exploitation of Marine Resources , 2012 .

[148]  R. Sen,et al.  ENZYMATIC PROCESSING OF CHITINACEOUS WASTES FOR N-ACETYL-D-GLUCOSAMINE PRODUCTION: AN EXAMPLE OF GREEN AND EFFICIENT ENVIRONMENTAL MANAGEMENT , 2012 .

[149]  R. Haut,et al.  The Effect of Glucosamine and Chondroitin on Stressed Equine Cartilage Explants , 2012 .

[150]  P. G. Gibbs,et al.  Plasma Concentration of Glucosamine and Chondroitin Sulfate in Horses after an Oral Dose , 2012 .

[151]  J. Block,et al.  The effects of oral glucosamine on joint health: is a change in research approach needed? , 2010, Osteoarthritis and cartilage.

[152]  Y. Lee,et al.  Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis , 2009, Rheumatology International.

[153]  W. Spiker,et al.  A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis. , 2009, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[154]  Robert M Lauder,et al.  Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems. , 2009, Complementary therapies in medicine.

[155]  L. Punzi,et al.  Influence of glucosamine sulphate on oxidative stress in human osteoarthritic chondrocytes: effects on HO-1, p22(Phox) and iNOS expression. , 2008, Rheumatology.

[156]  J. Reginster,et al.  Glucosamine and Chondroitin Sulfate as Therapeutic Agents for Knee and Hip Osteoarthritis , 2007, Drugs & aging.

[157]  K. Surapaneni,et al.  Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis. , 2007, Indian journal of medical sciences.

[158]  J. Elisseeff,et al.  Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. , 2007, Osteoarthritis and cartilage.

[159]  E. D. de Bruin,et al.  Chondroitin sulfate as a structure-modifying agent. , 2006, Advances in pharmacology.

[160]  J. Marier,et al.  Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. , 2005, Arthritis and rheumatism.

[161]  F. Cicuttini,et al.  The effect of nutritional supplements on osteoarthritis. , 2004, Alternative medicine review : a journal of clinical therapeutic.

[162]  C. Perry,et al.  Glucosamine: a review of its use in the management of osteoarthritis. , 2003, Drugs & aging.

[163]  J. Zaia,et al.  Structural analysis of cartilage proteoglycans and glycoproteins using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2000, Analytical biochemistry.

[164]  B. Leeb,et al.  A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. , 2000, The Journal of rheumatology.

[165]  V. Ramos,et al.  Enzymatic Depolymerization of Chitins and Chitosans , 1999 .

[166]  A. Fosang.  Aggrecanase and cartilage proteoglycan degradation , 1999 .

[167]  A. Conte,et al.  Metabolic fate of partially depolymerized shark chondroitin sulfate in man. , 1993, International journal of clinical pharmacology research.